<DOC>
	<DOC>NCT02812797</DOC>
	<brief_summary>The purpose of this study is to determine whether expressions of adipokines can provide prognostic information concerning patients with chronic heart failure.</brief_summary>
	<brief_title>Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients who are giving open chest surgical treatment with a history of chronic heart failure (NYHA II ~ IV) more than 6 months. Patients from whom informed consent has been properly obtained in writing prior to start of the trial. Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases,or any other malignancy. Patients with a history of cardiomyopathy. Patients with Chronic arrhythmia. Pregnant women Severe hepatic dysfunction or Endstage renal failure. Uncontrolled hypertension.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Adipokines</keyword>
	<keyword>Chronic Heart Failure</keyword>
	<keyword>Prognosis</keyword>
</DOC>